ImmuCell Stock Price, News & Analysis (NASDAQ:ICCC)

$8.75 -0.19 (-2.13 %)
(As of 12/18/2017 01:32 PM ET)
Previous Close$8.94
Today's Range$8.75 - $8.95
52-Week Range$5.00 - $9.25
Volume8,900 shs
Average Volume8,015 shs
Market Capitalization$44.20 million
P/E Ratio875
Dividend YieldN/A
Beta1.18

About ImmuCell (NASDAQ:ICCC)

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.

Receive ICCC News and Ratings via Email

Sign-up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:ICCC
CUSIPN/A
Phone207-878-2770

Debt

Debt-to-Equity Ratio0.27%
Current Ratio1.75%
Quick Ratio0.99%

Price-To-Earnings

Trailing P/E Ratio875
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$9.54 million
Price / Sales4.63
Cash Flow$0.27 per share
Price / Cash32.42
Book Value$4.07 per share
Price / Book2.15

Profitability

Trailing EPS$0.01
Net Income$500,000.00
Net Margins0.60%
Return on Equity0.28%
Return on Assets0.21%

Miscellaneous

Employees45
Outstanding Shares5,050,000

ImmuCell (NASDAQ:ICCC) Frequently Asked Questions

What is ImmuCell's stock symbol?

ImmuCell trades on the NASDAQ under the ticker symbol "ICCC."

How were ImmuCell's earnings last quarter?

ImmuCell Corporation (NASDAQ:ICCC) announced its earnings results on Monday, November, 13th. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $2.01 million for the quarter. ImmuCell had a net margin of 0.60% and a return on equity of 0.28%. View ImmuCell's Earnings History.

When will ImmuCell make its next earnings announcement?

ImmuCell is scheduled to release their next quarterly earnings announcement on Thursday, February, 8th 2018. View Earnings Estimates for ImmuCell.

Who are some of ImmuCell's key competitors?

Who are ImmuCell's key executives?

ImmuCell's management team includes the folowing people:

  • David Scott Tomsche, Independent Chairman of the Board (Age 59)
  • Michael F. Brigham, President, Chief Executive Officer, Treasurer, Secretary, Director (Age 54)
  • Elizabeth Luttrell Williams, Vice President - Manufacturing Operations
  • Paul R. Wainman, Director (Age 50)
  • David S. Cunningham, Independent Director (Age 49)
  • Jonathan E. Rothschild, Independent Director (Age 61)

Who owns ImmuCell stock?

ImmuCell's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include ROTHSCHILD JONATHAN E (10.10%) and Essex Investment Management Co. LLC (0.53%). Company insiders that own ImmuCell stock include Brian L Pessin, David Cunningham, David Scott Tomsche and Joseph H Crabb. View Institutional Ownership Trends for ImmuCell.

Who bought ImmuCell stock? Who is buying ImmuCell stock?

ImmuCell's stock was bought by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC. Company insiders that have bought ImmuCell stock in the last two years include Brian L Pessin, David Cunningham and David Scott Tomsche. View Insider Buying and Selling for ImmuCell.

How do I buy ImmuCell stock?

Shares of ImmuCell can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ImmuCell's stock price today?

One share of ImmuCell stock can currently be purchased for approximately $8.75.

How big of a company is ImmuCell?

ImmuCell has a market capitalization of $44.20 million and generates $9.54 million in revenue each year. The biotechnology company earns $500,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. ImmuCell employs 45 workers across the globe.

How can I contact ImmuCell?

ImmuCell's mailing address is 56 EVERGREEN DR, PORTLAND ME, 04103. The biotechnology company can be reached via phone at 207-878-2770 or via email at [email protected]


MarketBeat Community Rating for ImmuCell (ICCC)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  26 (Vote Underperform)
Total Votes:  59
MarketBeat's community ratings are surveys of what our community members think about ImmuCell and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ImmuCell (NASDAQ:ICCC) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

ImmuCell (NASDAQ:ICCC) Earnings History and Estimates Chart

Earnings by Quarter for ImmuCell (NASDAQ:ICCC)

ImmuCell (NASDAQ ICCC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2018        
11/13/2017Q3 2017($0.07)$2.01 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.05)$1.75 millionViewN/AView Earnings Details
5/11/2017Q1 2017$0.12$3.54 millionViewN/AView Earnings Details
2/9/2017Q416$0.01$2.70 million$2.20 millionViewListenView Earnings Details
11/10/2016Q316$0.01$1.61 million$1.97 millionViewN/AView Earnings Details
5/11/2016Q1$0.11$2.99 millionViewN/AView Earnings Details
2/10/2016Q315$0.09$2.21 million$2.70 millionViewListenView Earnings Details
11/12/2015Q3$0.11$2.47 millionViewListenView Earnings Details
8/13/2015Q215$0.03$1.54 million$1.96 millionViewN/AView Earnings Details
2/11/2015Q414$0.04$1.56 million$2.21 millionViewN/AView Earnings Details
8/12/2014Q214($0.10)$1.37 million$1.54 millionViewN/AView Earnings Details
2/13/2014Q413($0.05)$1.42 million$1.56 millionViewN/AView Earnings Details
11/12/2013Q313$0.02$1.08 million$1.24 millionViewN/AView Earnings Details
11/7/2012Q312($0.02)$1.00 million$1.08 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

ImmuCell (NASDAQ:ICCC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ImmuCell (NASDAQ:ICCC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

ImmuCell (NASDAQ ICCC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 20.10%
Institutional Ownership Percentage: 13.22%
Insider Trades by Quarter for ImmuCell (NASDAQ:ICCC)
Institutional Ownership by Quarter for ImmuCell (NASDAQ:ICCC)

ImmuCell (NASDAQ ICCC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2017Brian L PessinInsiderBuy30,000$5.25$157,500.00View SEC Filing  
3/14/2017David Scott TomscheDirectorBuy2,000$5.43$10,860.00View SEC Filing  
11/7/2016David Scott TomscheDirectorBuy4,000$5.19$20,760.00View SEC Filing  
7/8/2016Joseph H CrabbVPSell1,935$6.55$12,674.25View SEC Filing  
7/7/2016Joseph H CrabbVPSell2,691$6.58$17,706.78View SEC Filing  
7/5/2016Joseph H CrabbVPSell5,374$6.74$36,220.76View SEC Filing  
3/21/2016David Scott TomscheDirectorBuy955$6.67$6,369.85View SEC Filing  
1/29/2016David CunninghamDirectorBuy1,904$5.25$9,996.00View SEC Filing  
9/3/2015Jonathan E. RothschildDirectorBuy3,000$6.63$19,890.00View SEC Filing  
9/1/2015David Scott TomscheDirectorBuy1,000$6.73$6,730.00View SEC Filing  
8/31/2015Jonathan E. RothschildDirectorBuy6,100$7.37$44,957.00View SEC Filing  
8/28/2015David Scott TomscheDirectorBuy1,500$7.27$10,905.00View SEC Filing  
11/26/2014Jonathan E RothschildDirectorBuy2,100$4.82$10,122.00View SEC Filing  
8/20/2014Jonathan E RothschildDirectorBuy3,000$4.55$13,650.00View SEC Filing  
6/16/2014Jonathan E RothschildDirectorBuy5,901$4.57$26,967.57View SEC Filing  
5/15/2014David CunninghamDirectorBuy1,500$3.91$5,865.00View SEC Filing  
8/23/2013Jonathan E RothschildDirectorBuy1,500$3.98$5,970.00View SEC Filing  
8/16/2013David CunninghamDirectorBuy4,000$3.68$14,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

ImmuCell (NASDAQ ICCC) News Headlines

Source:
DateHeadline
ImmuCell Corporation (ICCC) Releases  Earnings ResultsImmuCell Corporation (ICCC) Releases Earnings Results
www.americanbankingnews.com - November 14 at 9:56 AM
Edited Transcript of ICCC earnings conference call or presentation 13-Nov-17 9:30pm GMTEdited Transcript of ICCC earnings conference call or presentation 13-Nov-17 9:30pm GMT
finance.yahoo.com - November 14 at 5:47 AM
ImmuCell Corps (ICCC) CEO Michael Brigham on Q3 2017 Results - Earnings Call TranscriptImmuCell Corp's (ICCC) CEO Michael Brigham on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 12:46 AM
Immucell Corp (ICCC) Announces USDA Approval of New Product Claim to Prevent Rotavirus InfectionsImmucell Corp (ICCC) Announces USDA Approval of New Product Claim to Prevent Rotavirus Infections
www.streetinsider.com - November 13 at 7:46 PM
ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus InfectionsImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections
finance.yahoo.com - November 13 at 7:46 PM
ImmuCell Announces Financial Results for Third Quarter of 2017ImmuCell Announces Financial Results for Third Quarter of 2017
finance.yahoo.com - November 13 at 7:46 PM
ImmuCell Announces Completion of Construction of Nisin Production FacilityImmuCell Announces Completion of Construction of Nisin Production Facility
finance.yahoo.com - November 8 at 10:04 AM
ImmuCell Corporation (ICCC) Scheduled to Post Earnings on MondayImmuCell Corporation (ICCC) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - November 6 at 12:17 PM
ImmuCell to Announce Financial Results for Third Quarter of 2017ImmuCell to Announce Financial Results for Third Quarter of 2017
finance.yahoo.com - November 3 at 8:51 AM
ImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017ImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 8:12 PM
Did ImmuCell Corporation (ICCC) Create Value For Investors Over The Past Year?Did ImmuCell Corporation (ICCC) Create Value For Investors Over The Past Year?
finance.yahoo.com - October 5 at 10:47 AM
ImmuCell Announces Expansion of Sales and Marketing TeamImmuCell Announces Expansion of Sales and Marketing Team
finance.yahoo.com - September 14 at 6:18 AM
ImmuCell Corps (ICCC) CEO Michael Brigham on Q2 2017 Results - Earnings Call TranscriptImmuCell Corp's (ICCC) CEO Michael Brigham on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 11:55 PM
Edited Transcript of ICCC earnings conference call or presentation 14-Aug-17 8:30pm GMTEdited Transcript of ICCC earnings conference call or presentation 14-Aug-17 8:30pm GMT
finance.yahoo.com - August 15 at 11:55 PM
Investor Network: ImmuCell Corporation to Host Earnings CallInvestor Network: ImmuCell Corporation to Host Earnings Call
finance.yahoo.com - August 14 at 10:03 PM
ImmuCell Announces Financial Results for Second Quarter of 2017ImmuCell Announces Financial Results for Second Quarter of 2017
finance.yahoo.com - August 14 at 10:03 PM
ImmuCell Co. (NASDAQ:ICCC) Announces Quarterly  Earnings ResultsImmuCell Co. (NASDAQ:ICCC) Announces Quarterly Earnings Results
www.americanbankingnews.com - August 14 at 8:22 PM
ImmuCell to Announce Financial Results for Second Quarter of 2017ImmuCell to Announce Financial Results for Second Quarter of 2017
finance.yahoo.com - August 7 at 7:11 PM
Insider Buying: ImmuCell Corporation (ICCC) Insider Buys 30,000 Shares of StockInsider Buying: ImmuCell Corporation (ICCC) Insider Buys 30,000 Shares of Stock
www.americanbankingnews.com - July 28 at 7:35 PM
ImmuCell Closes $1,000,000 Equity InvestmentImmuCell Closes $1,000,000 Equity Investment
finance.yahoo.com - July 27 at 10:14 PM
ImmuCell Unveils New WebsiteImmuCell Unveils New Website
finance.yahoo.com - July 17 at 3:42 PM
ImmuCell Clarifies Number of Authorized Common SharesImmuCell Clarifies Number of Authorized Common Shares
finance.yahoo.com - July 14 at 3:18 AM
IMMUCELL CORP /DE/ Files SEC form 10-K, Annual ReportIMMUCELL CORP /DE/ Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 6:12 PM
IMMUCELL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Entry into a Material Definitive AgIMMUCELL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Entry into a Material Definitive Ag
biz.yahoo.com - March 8 at 6:36 PM
IMMUCELL CORP /DE/ Files SEC form 8-K, Other EventsIMMUCELL CORP /DE/ Files SEC form 8-K, Other Events
biz.yahoo.com - March 2 at 6:11 PM
ImmuCell Corporation (ICCC)ImmuCell Corporation (ICCC)
seekingalpha.com - February 11 at 5:53 PM
IMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial ConditionIMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - February 10 at 6:34 PM
Q4 2016 ImmuCell Corp Earnings Release - After Market CloseQ4 2016 ImmuCell Corp Earnings Release - After Market Close
biz.yahoo.com - February 9 at 6:43 PM
ImmuCells (ICCC) CEO Michael Brigham on Q3 2016 Results - Earnings Call TranscriptImmuCell's (ICCC) CEO Michael Brigham on Q3 2016 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 8:02 AM
Immucell Corp (ICCC) Reports Q3 EPS of $0.01Immucell Corp (ICCC) Reports Q3 EPS of $0.01
www.streetinsider.com - November 12 at 8:02 AM
IMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - October 21 at 5:39 PM
Immucell Corp (ICCC) Offers Prelim. Q3 Results; Says Sales Fell 20%Immucell Corp (ICCC) Offers Prelim. Q3 Results; Says Sales Fell 20%
www.streetinsider.com - October 19 at 10:27 AM
ImmuCell Announces Preliminary Third Quarter 2016 Financial ResultsImmuCell Announces Preliminary Third Quarter 2016 Financial Results
www.streetinsider.com - October 18 at 10:37 AM
ImmuCell to Raise $3.5 Million in Private PlacementImmuCell to Raise $3.5 Million in Private Placement
www.marketwatch.com - October 18 at 10:37 AM
IMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive AgreementIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - October 18 at 10:37 AM
ImmuCell Announces Second Quarter 2016 Financial ResultsImmuCell Announces Second Quarter 2016 Financial Results
www.finanznachrichten.de - August 13 at 8:31 AM
ImmuCells (ICCC) CEO Michael Brigham on Q2 2016 Results - Earnings Call TranscriptImmuCell's (ICCC) CEO Michael Brigham on Q2 2016 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 8:31 AM
Immucell Corp (ICCC) Reports Q2 EPS of $0.00Immucell Corp (ICCC) Reports Q2 EPS of $0.00
www.streetinsider.com - August 13 at 8:31 AM
Q2 2016 ImmuCell Corp Earnings Release - After Market CloseQ2 2016 ImmuCell Corp Earnings Release - After Market Close
biz.yahoo.com - August 11 at 8:36 AM
IMMUCELL CORP /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders, Financial Statements anIMMUCELL CORP /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders, Financial Statements an
biz.yahoo.com - June 16 at 3:35 PM

SEC Filings

ImmuCell (NASDAQ:ICCC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

ImmuCell (NASDAQ:ICCC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ImmuCell (NASDAQ ICCC) Stock Chart for Monday, December, 18, 2017

Loading chart…

This page was last updated on 12/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.